Foot-and-mouth disease (FMD) is caused by 7 immunologically distinct serotypes, O, A, C, Asia 1, South African Territories (SAT) 1, SAT 2, and SAT 3, which belong to the species *Foot-and-mouth disease virus* (genus *Aphthovirus*, family *Picornaviridae*). Several of these serotypes circulate currently or periodically in the Middle East and North Africa ([@R1]). In Egypt, routine prophylactic vaccination has been conducted with a locally produced serotype O vaccine. The last outbreak of serotype O was in June 2000, and other serotypes have not been reported since 1972 when serotype A occurred ([@R2]). This report describes an FMD serotype A virus responsible for recent outbreaks of disease in Egypt.

Clinical cases of FMD were first recognized on January 22, 2006, on a cattle farm at El Etehad in Ismailia, northeastern Egypt ([Figure 1](#F1){ref-type="fig"}). Samples were submitted for laboratory investigation and serotype determination by using virus isolation, antigen ELISA, and reverse transcription--PCR (RT-PCR). Initial testing with antigen ELISA and RT-PCR assays suggested that multiple FMD virus (FMDV) serotypes may have been involved in the outbreak (data not shown), although only type A was later confirmed. On February 15, 2006, the Agriculture Ministry in Egypt notified international public health authorities (by reporting to the World Organization for Animal Health \[OIE\]) of 6 outbreaks of FMDV caused by serotype A in Ismailia and 12 additional outbreaks in 7 other Egyptian governorates: Alexandria (2 outbreaks), Behera (1 outbreak), Cairo (1 outbreak), Dakahlia (1 outbreak), Dumyat (5 outbreaks), Fayum (1 outbreak), and Menofia (1 outbreak). By April 6, 2006, 34 outbreaks of disease had been reported that affected \>7,500 animals and involved an additional governorate (Kalubia). Most (96.7%) clinical FMD cases involved cattle; 411 cattle (mainly calves) reportedly died. Attempts to control the outbreaks were hampered by lack of an appropriate vaccine and concurrent outbreaks of highly pathogenic avian influenza. FMD became widespread in Egypt, with the following numbers of animals affected per month: 6,189 (January), 1,858 (February), 3,035 (March), 401 (April), and 297 (May). A locally produced bivalent FMDV vaccine, containing both O~1~ and A/Egypt/2006 isolates, was released in mid-May 2006 for the first time in Egypt. No new cases have been reported since July 2006.
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The Study
=========

Clinical material from 5 cases (collected from 3 separate locations in Egypt; [Table 1](#T1){ref-type="table"}) was sent to the Food and Agricultural Organization of the United Nations (FAO) World Reference Laboratory for FMD (WRLFMD) at the Institute for Animal Health, Pirbright, United Kingdom, for confirmatory diagnosis and characterization of the causative FMDV strain(s). The possibility that these samples contained multiple FMDV serotypes was also investigated. FMDV isolates causing cytopathic effects in primary bovine thyroid (BTy) cell cultures were generated from all samples. The cell culture--grown virus isolates and original clinical submissions were identified as FMDV serotype A by antigen-detection ELISA ([@R3]).

###### Foot-and-mouth disease type A viruses examined in the study

  WRLFMD ref. no. or virus name\*   Location                                 Date collected   Species     GenBank accession no.
  --------------------------------- ---------------------------------------- ---------------- ----------- -----------------------
  A/ARG/2000                        Argentina                                2000             Not known   AY593782
  A/Trenquelauquen/ ARG/2001        Trenquelauquen, Argentina                Mar 31, 2001     Bovine      AY593786
  A~24~/Cruzeiro/BRA/55             Cruzeiro, Brazil                         1955             Bovine      AJ251476
  A/CAR/15/2000                     Lahore Vina, Vina, Adamawa, Cameroon     2000             Bovine      EF208755
  A/EGY/1/72                        Alexandria, Egypt                        May 13, 1972     Bovine      EF208756
  A/EGY/1/2006                      Ismailia, Egypt                          Feb 9, 2006      Bovine      EF208757
  A/EGY/2/2006                      Ismailia, Egypt                          Feb 9, 2006      Bovine      EF208758
  A/EGY/3/2006                      Ismailia, Egypt                          Feb 9, 2006      Bovine      EF208759
  A/EGY/4/2006                      Fayoum, Egypt                            Feb 16, 2006     Bovine      EF208760
  A/EGY/5/2006                      Domiat, Egypt                            Feb 19, 2006     Bovine      EF208761
  A/ETH/7/92                        Shena, Ethiopia                          Oct 3, 1992      Bovine      EF208765
  A/ETH/1/94                        Highland areas of Eastern Ethiopia       Feb 2, 1994      Bovine      EF208766
  A/ETH/23/94                       Nazret, East Shoa, Ethiopia              Mar 9, 1994      Not known   EF208767
  A~5~/Allier/FRA/60                Allier, France                           1960             Bovine      AY593780
  A/GAM/44/98                       Gambia                                   Feb 4, 1998      Not known   EF208768
  A~10~/HOL/42                      Groot-Ammers, the Netherlands            1942             Bovine      M20715
  A/IND/17/77†                      Tamil Nadu, India                        1977             Bovine      AF204108
  A/IRN/2/87                        Mardabad, Kardaj, Tehran, Iran           Mar 11,1987      Bovine      EF208770
  A/IRN/1/96                        Zarnan, Shahriar, Tehran, Iran           Nov 13, 1996     Bovine      EF208771
  A/IRN/22/99                       Tabriz, East Azerbaijan Province, Iran   1999             Bovine      EF208772
  A/IRN/1/2005                      Ghalch-Sadri, Qom, Qom Province, Iran    Apr 4, 2005      Bovine      EF208769
  A~22~/IRQ/24/64                   Mosul, Iraq                              1964             Bovine      AJ251474
  A~21~/Lumbwa/KEN/64               Lumbwa, Kenya                            1964             Bovine      AY593761
  A~23~/Kitale/KEN/64               Kitale, Kenya                            1964             Bovine      AY593766
  A/KEN/15/98                       Meru, Kenya                              Sep 8, 1998      Bovine      EF208774
  A/KEN/16/98A                      Nakuru, Kenya                            Sep 15, 1998     Bovine      EF208775
  A/KEN/29/2005                     Embu, Eastern Province, Kenya            Aug 24, 2005     Bovine      EF208773
  A/MAI/2/97                        Mali                                     Not known        Not known   EF208776
  A~15~/Bangkok/TAI/60              Bangkok, Thailand                        1960             Bovine      AY593755
  A/TAI/118/87†                     Sara Buri, Thailand                      1987             Not known   EF208777
  A/TAI/2/97                        Thailand                                 1997             Not known   EF208778
  A~12~/UK/119/32                   Kent, United Kingdom                     1932             Bovine      AY593752

\*WRLFMD, World Reference Laboratory for Foot-and-Mouth Disease. †Not a WRLFMD reference no.

Total RNA was extracted from the first virus passage on BTy cells by using RNeasy kits (QIAGEN, Crawley, UK) for all 5 samples (EGY/1/2006--EGY/5/2006) ([@R4]). The complete VP1 region of the genome was amplified by RT-PCR by using 2 primer sets (A-1C562F/EUR-2B52R and A-1C612F/EUR-2B52R; [Table 2](#T2){ref-type="table"}) and the following thermal profile: 42°C for 30 min; 94°C for 5 min; 35 cycles of 94°C for 60 s, 55°C for 60 s, and 72°C for 90 s, followed by a final extension of 72°C for 5 min. The sequence of each amplicon was determined by cycle sequencing as previously described ([@R4]) but with the primers NK72, A-1C612F, and A-1D523R ([Table 2](#T2){ref-type="table"}). An unrooted neighbor-joining tree was constructed by using MEGA version 3.1 ([@R5]). The robustness of the tree topology was assessed with 1,000 bootstrap replicates as implemented in the program. Additionally, maximum parsimony (MEGA 3.1), minimum evolution (MEGA 3.1), and maximum likelihood (TREE-PUZZLE 5.2; \[[@R6]\]) trees were constructed; all 4 methods gave similar tree topologies (data not shown). Egyptian sequences shared a closer phylogenetic relationship with recent and historical isolates from East Africa rather than with contemporary serotype A viruses emerging from Iran, currently circulating in the Middle East and European Turkey ([Figure 2](#F2){ref-type="fig"}).

###### Oligonucleotide primers used for RT-PCR and sequencing\*

  Primer name   Primer sequence (5′→3′)      Sense     Gene    Position†
  ------------- ---------------------------- --------- ------- ------------
  A-1C562F      TACCAAATTACACACGGGAA         Forward   VP3     3123--3142
  A-1C612F      TAGCGCCGGCAAAGACTTTGA        Forward   VP3     3173--3193
  EUR-2B52R     GACATGTCCTCCTGCATCTGGTTGAT   Reverse   2B      3963--3988
  NK72          GAAGGGCCCAGGGTTGGACTC        Reverse   2A/2B   3897--3917
  A-1D523R      CGTTTCATRCGCACRAGRA          Reverse   VP1     3748--3766

\*RT-PCR, reverse transcription--PCR. †Position on the genome of A~21~/Lumbwa/KEN/64 (GenBank accession no. AY593761).
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Other conventional "typing" PCRs were performed to investigate whether additional FMDV serotypes were present in these samples. A multiplex agarose gel--based RT-PCR that targeted VP1 of O, A, C, and Asia 1 (primers P33, P38, P87--92, P40, P74--77) ([@R7]) generated a single band corresponding to the size expected (702 bp) for serotype A for all 5 samples (data not shown). In addition, a cocktail of primers (P1, P126, P150--153, P130, P159--161, P168--170) ([@R7]) recognizing VP1 of SAT1--3 serotypes did not show any bands after RT-PCR with these samples. However, amplicons of correct size (715 bp) were obtained after RT-PCR with samples EGY/1/2006, EGY/3/2006, and EGY/5/2006 when an additional primer set for SAT 1--3 VP1 (1D209F/2B208R) was used ([@R8]). Subsequent analysis of these SAT amplicons generated sequences that corresponded to serotype A, identical to the complete VP1 sequences of A/EGY/1/2006 and A/EGY/2/2006. Together, these findings support the conclusion that FMDV corresponding to a single serotype A was present in this material.

For vaccine selection, serologic tests were conducted to evaluate the extent of in vitro cross-neutralization of A/EGY/1/2006 and A/EGY/2/2006 by antisera produced against available FMDV vaccine strains ([@R9]). The match (r~1~ value) against the vaccine strains A~22~/Iraq/64 and A/Iran/96 that are regularly used elsewhere in the Middle East was less than the cut-off value of 0.3 (r~1~ = 0.23 and 0.24, respectively), whereas an acceptable match (r~1~ = 0.42) was found against the A/Eritrea/98 vaccine strain that is of East African origin. However, A/Eritrea/98 vaccine is not in routine production nor held in vaccine reserves and was therefore not available for immediate supply. A recent in vivo study demonstrated that a high potency A~22~/Iraq/64 vaccine could provide clinical protection against challenge with the new A/EGY/2006 virus (B. Haas, pers. comm., 2006). High-potency vaccines are known to protect even when relationship values are lower than the normal cut-off values ([@R10]).

Conclusions
===========

Local interpretation of agarose-based RT-PCR assays and sequence data led the Egyptian authorities to initially suspect the involvement of at least 2 serotypes, A and SAT 2. However, tests performed at the WRLFMD conclusively showed the presence of a single serotype, A, in the samples received from Egypt. Unofficial reports suggest that the disease was introduced by animals imported from Ethiopia for slaughter ([@R11]). This hypothesis is consistent with the results of the molecular typing, which suggested a relation between strains of Egyptian and East African origin. The molecular typing confirms only that through the trade in live cattle, an East African type A strain was introduced, which was not contained at the quarantine station. The origin of the infection is unclear, since the animals in quarantine may have acquired infection at various points during shipment, including possible contaminated pens or other animals on board the ship, at the port before loading, or in transit from Ethiopia to the port of loading. Veterinary inspection of the quarantined animals also detected cases of lumpy skin disease (LSD), and possibly the origin of the LSD epidemic in Egypt in 2006 may relate to the Ethiopian animal trade, which is supported by the reports of LSD epidemics in Ethiopia in 2005. Undoubtedly, the lack of reporting of disease preimportation or at the quarantine stations did not assist the authorities in controlling the disease. Because imported animals may acquire infection at any point up until their arrival, they must be vaccinated and tested for the absence of FMDV nonstructural proteins.
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